Brief: Theseus Pharmaceuticals Confirms Receipt Of Unsolicited Expression Of Interest From Foresite Capital, Orbimed Advisors And Unsolicited Proposal From Concentra Biosciences
27/11/2023 12:09
Nov 27 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* THESEUS PHARMACEUTICALS CONFIRMS RECEIPT OF UNSOLICITED
EXPRESSION OF INTEREST FROM FORESITE CAPITAL, LLC AND ORBIMED
ADVISORS LLC AND UNSOLICITED PROPOSAL FROM CONCENTRA BIOSCIENCES
LLC
* THESEUS PHARMACEUTICALS - ON NOV 24, BOARD RECEIVED AN
UNSOLICITED PROPOSAL FROM TANG CAPITAL PARTNERS, LP ON BEHALF OF
CONCENTRA BIOSCIENCES LLC
* THESEUS PHARMACEUTICALS INC - UNSOLICITED PROPOSAL FROM
TANG
CAPITAL PARTNERS FOR ALL CO'S OUTSTANDING SHARES COMMON STOCK
FOR $3.80/ SHARE IN CASH
Source text for Eikon: ID:nPn6YM54fa
Further company coverage: THRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7